Zhongyue Yuan
Materials Science · Purdue University West Lafayette
Publications
18
Citations
608
Est. group size
~1
Recurring co-author estimate
Active years
13
Publishing since 2013
Zhongyue Yuan's work focuses on designing nanoparticle-based drug delivery systems, especially for treating cancers such as breast, liver, and lung cancer. Much of the research involves engineering carriers (like hyaluronic acid or lipid-based nanoparticles) to deliver chemotherapy drugs (such as doxorubicin) more precisely to tumors while triggering immune responses against cancer cells. Recent work also touches on combining these delivery systems with immunotherapy and cell-death mechanisms like ferroptosis (a form of cell death driven by iron and oxidative damage).
Publication output has been irregular over the last decade, with a notable gap in 2023 followed by a sharp increase in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia
Frontiers in Cell and Developmental Biology · 2025
- ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade
Chinese Chemical Letters · 2025
- Self-amplifying tumor-targeting nanoreactor for enhanced Immuno-Ferroptosis therapy in triple-negative breast cancer
Chemical Engineering Journal · 2025
- Corrigendum to “Doxorubicin delivered by redox-responsive Hyaluronic Acid–Ibuprofen prodrug micelles for treatment of metastatic breast cancer” [Carbohydrate Polymers 245 (2020) 116527]
Carbohydrate Polymers · 2025
- Development of Miriplatin-loaded Nanoparticles against Non-small Cell Lung Cancer
Scholarly Commons (University of the Pacific) · 2021
- Doxorubicin delivered by redox-responsive Hyaluronic Acid–Ibuprofen prodrug micelles for treatment of metastatic breast cancer
Carbohydrate Polymers · 2020
- Fibroblast activation protein-α-adaptive micelles deliver anti-cancer drugs and reprogram stroma fibrosis
Nanoscale · 2020
- Abstract 312: Multicellular spheroids of A549 cells: A clinically relevant model of lung cancer
Cancer Research · 2020
- Development of Lipid-based Nano Formulations of Miriplatin Against Lung Cancer
Scholarly Commons (University of the Pacific) · 2020
- Preparation and evaluation of orally disintegrating film containing donepezil for Alzheimer disease
Journal of Drug Delivery Science and Technology · 2019
- Desirable PEGylation for improving tumor selectivity of hyaluronic acid-based nanoparticles via low hepatic captured, long circulation times and CD44 receptor-mediated tumor targeting
Nanomedicine Nanotechnology Biology and Medicine · 2019
- Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy
International Journal of Pharmaceutics · 2017
- Chitosan nanoparticles and their Tween 80 modified counterparts disrupt the developmental profile of zebrafish embryos
International Journal of Pharmaceutics · 2016
- Advanced Drug Delivery Reviews×2
- Carbohydrate Polymers×2
- International Journal of Pharmaceutics×2
- Scholarly Commons (University of the Pacific)×2
- Journal of Drug Delivery Science and Technology×1
- Zhili Xu
Materials Science · Indiana University
- Pranay Agarwal
Materials Science · The Ohio State University
- Kim Truc Nguyen
Materials Science · The Ohio State University
- Dipak Maity
Materials Science · Indiana University
- Hitesh Kumar Waghwani
Materials Science · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile